Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304754976> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W4304754976 endingPage "2776" @default.
- W4304754976 startingPage "2768" @default.
- W4304754976 abstract "Abstract STUDY QUESTION Is a strategy starting with transvaginal hydrolaparoscopy (THL) cost-effective compared to a strategy starting with hysterosalpingography (HSG) in the work-up for subfertility? SUMMARY ANSWER A strategy starting with THL is cost-effective compared to a strategy starting with HSG in the work-up for subfertile women. WHAT IS KNOWN ALREADY Tubal pathology is a common cause of subfertility and tubal patency testing is one of the cornerstones of the fertility work-up. Both THL and HSG are safe procedures and can be used as a first-line tubal patency test. STUDY DESIGN, SIZE, DURATION This economic evaluation was performed alongside a randomized clinical trial comparing THL and HSG in 300 subfertile women, between May 2013 and October 2016. For comparisons of THL and HSG, the unit costs were split into three main categories: costs of the diagnostic procedure, costs of fertility treatments and the costs for pregnancy outcomes. PARTICIPANTS/MATERIALS, SETTING, METHODS Subfertile women scheduled for tubal patency testing were eligible. Women were randomized to a strategy starting with THL or a strategy starting with HSG. The primary outcome of the study was conception leading to a live birth within 24 months after randomization. The mean costs and outcomes for each treatment group were compared. We used a non-parametric bootstrap resampling of 1000 re-samples to investigate the effect of uncertainty and we created a cost-effectiveness plane and cost-effectiveness acceptability curves. MAIN RESULTS AND THE ROLE OF CHANCE We allocated 149 women to THL and 151 to HSG, and we were able to achieve complete follow-up of 142 versus 148 women, respectively. After the fertility work-up women were treated according to the Dutch guidelines and based on a previously published prognostic model. In the THL group, 83 women (58.4%) conceived a live born child within 24 months after randomization compared to 82 women (55.4%) in the HSG group (difference 3.0% (95% CI: −8.3 to 14.4)). The mean total costs per woman were lower in the THL group compared to the HSG group (THL group €4991 versus €5262 in the HSG group, mean cost difference = −€271 (95% CI −€273 to −€269)). Although the costs of only the diagnostic procedure were higher in the THL group, in the HSG group more women underwent diagnostic and therapeutic laparoscopies and also had higher costs for fertility treatments. LIMITATIONS, REASONS FOR CAUTION Our trial was conducted in women with a low risk of tubal pathology; therefore, the results of our study are not generalizable to women with high risk of tubal pathology. Furthermore, this economic analysis was based on the Dutch healthcare system, and possibly our results are not generalizable to countries with different strategies or costs for fertility treatments. WIDER IMPLICATIONS OF THE FINDINGS After 2 years of follow-up, we found a live birth rate of 58.4% in the THL group versus 55.4% in the HSG group and a lower mean cost per woman in the THL group, with a cost difference of −€271. The findings of our trial suggest that a strategy starting with THL is cost-effective compared to a strategy starting with HSG in the workup for subfertile women. However, the cost difference between the two diagnostic strategies is limited compared to the total cost per woman in our study and before implementing THL as a first-line strategy for tubal patency testing, more research in other fields, such as patient preference and acceptance, is necessary. STUDY FUNDING/COMPETING INTEREST(S) The authors received no external financial support for the research. B.W.J.M. is supported by an NHMRC Investigator Grant (GNT1176437). B.W.J.M. reports consultancy for ObsEva, Merck KGaA, Guerbet. B.W.J.M. reports receiving travel support from Merck KGaA. C.T.P. reports consultancy for Guerbet, outside of this manuscript. All other authors have no conflicts to declare. TRIAL REGISTRATION NUMBER NTR3462." @default.
- W4304754976 created "2022-10-13" @default.
- W4304754976 creator A5004286913 @default.
- W4304754976 creator A5024284481 @default.
- W4304754976 creator A5054727971 @default.
- W4304754976 creator A5065413089 @default.
- W4304754976 creator A5066811784 @default.
- W4304754976 creator A5076248162 @default.
- W4304754976 creator A5077604971 @default.
- W4304754976 creator A5090795384 @default.
- W4304754976 date "2022-10-12" @default.
- W4304754976 modified "2023-09-30" @default.
- W4304754976 title "The cost-effectiveness of transvaginal hydrolaparoscopy versus hysterosalpingography in the work-up for subfertility" @default.
- W4304754976 cites W1863500836 @default.
- W4304754976 cites W1897750445 @default.
- W4304754976 cites W2012198908 @default.
- W4304754976 cites W2020834928 @default.
- W4304754976 cites W2053728092 @default.
- W4304754976 cites W2098199441 @default.
- W4304754976 cites W2098534762 @default.
- W4304754976 cites W2121181978 @default.
- W4304754976 cites W2128078422 @default.
- W4304754976 cites W2131805980 @default.
- W4304754976 cites W2616364968 @default.
- W4304754976 cites W2780780487 @default.
- W4304754976 cites W2922297581 @default.
- W4304754976 cites W3034270615 @default.
- W4304754976 cites W3150835661 @default.
- W4304754976 cites W3157974155 @default.
- W4304754976 cites W3208795377 @default.
- W4304754976 cites W4235836229 @default.
- W4304754976 cites W4255924814 @default.
- W4304754976 doi "https://doi.org/10.1093/humrep/deac219" @default.
- W4304754976 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36223599" @default.
- W4304754976 hasPublicationYear "2022" @default.
- W4304754976 type Work @default.
- W4304754976 citedByCount "0" @default.
- W4304754976 crossrefType "journal-article" @default.
- W4304754976 hasAuthorship W4304754976A5004286913 @default.
- W4304754976 hasAuthorship W4304754976A5024284481 @default.
- W4304754976 hasAuthorship W4304754976A5054727971 @default.
- W4304754976 hasAuthorship W4304754976A5065413089 @default.
- W4304754976 hasAuthorship W4304754976A5066811784 @default.
- W4304754976 hasAuthorship W4304754976A5076248162 @default.
- W4304754976 hasAuthorship W4304754976A5077604971 @default.
- W4304754976 hasAuthorship W4304754976A5090795384 @default.
- W4304754976 hasConcept C112930515 @default.
- W4304754976 hasConcept C131872663 @default.
- W4304754976 hasConcept C141071460 @default.
- W4304754976 hasConcept C168563851 @default.
- W4304754976 hasConcept C2777688143 @default.
- W4304754976 hasConcept C2779234561 @default.
- W4304754976 hasConcept C2779245376 @default.
- W4304754976 hasConcept C2779492760 @default.
- W4304754976 hasConcept C2908647359 @default.
- W4304754976 hasConcept C29456083 @default.
- W4304754976 hasConcept C3019080777 @default.
- W4304754976 hasConcept C518429986 @default.
- W4304754976 hasConcept C54355233 @default.
- W4304754976 hasConcept C71924100 @default.
- W4304754976 hasConcept C86803240 @default.
- W4304754976 hasConcept C99454951 @default.
- W4304754976 hasConceptScore W4304754976C112930515 @default.
- W4304754976 hasConceptScore W4304754976C131872663 @default.
- W4304754976 hasConceptScore W4304754976C141071460 @default.
- W4304754976 hasConceptScore W4304754976C168563851 @default.
- W4304754976 hasConceptScore W4304754976C2777688143 @default.
- W4304754976 hasConceptScore W4304754976C2779234561 @default.
- W4304754976 hasConceptScore W4304754976C2779245376 @default.
- W4304754976 hasConceptScore W4304754976C2779492760 @default.
- W4304754976 hasConceptScore W4304754976C2908647359 @default.
- W4304754976 hasConceptScore W4304754976C29456083 @default.
- W4304754976 hasConceptScore W4304754976C3019080777 @default.
- W4304754976 hasConceptScore W4304754976C518429986 @default.
- W4304754976 hasConceptScore W4304754976C54355233 @default.
- W4304754976 hasConceptScore W4304754976C71924100 @default.
- W4304754976 hasConceptScore W4304754976C86803240 @default.
- W4304754976 hasConceptScore W4304754976C99454951 @default.
- W4304754976 hasIssue "12" @default.
- W4304754976 hasLocation W43047549761 @default.
- W4304754976 hasLocation W43047549762 @default.
- W4304754976 hasOpenAccess W4304754976 @default.
- W4304754976 hasPrimaryLocation W43047549761 @default.
- W4304754976 hasRelatedWork W2056867161 @default.
- W4304754976 hasRelatedWork W2071776052 @default.
- W4304754976 hasRelatedWork W2167770451 @default.
- W4304754976 hasRelatedWork W2325097716 @default.
- W4304754976 hasRelatedWork W2401739700 @default.
- W4304754976 hasRelatedWork W2594069839 @default.
- W4304754976 hasRelatedWork W2803263777 @default.
- W4304754976 hasRelatedWork W3194299896 @default.
- W4304754976 hasRelatedWork W3201319083 @default.
- W4304754976 hasRelatedWork W3203010433 @default.
- W4304754976 hasVolume "37" @default.
- W4304754976 isParatext "false" @default.
- W4304754976 isRetracted "false" @default.
- W4304754976 workType "article" @default.